Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003549961 | SCV004259961 | benign | not provided | 2023-07-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003549961 | SCV004700099 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | FAT2: BP4, BS2 |
Ambry Genetics | RCV004369005 | SCV004869935 | uncertain significance | not specified | 2022-01-04 | criteria provided, single submitter | clinical testing | The c.1211T>A (p.V404E) alteration is located in exon 1 (coding exon 1) of the FAT2 gene. This alteration results from a T to A substitution at nucleotide position 1211, causing the valine (V) at amino acid position 404 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |